By Kim Richters

The U.K. Competition and Markets Authority is reviewing Roche Holding AG's (RO.EB) planned acquisition of Spark Therapeutics Inc. (ONCE), the regulator said Wednesday.

Swiss pharmaceuticals company Roche announced plans to acquire U.S.-based biotechnology company Sparks in February this year.

The authority is considering whether a merger would lead to a substantial lessening of competition within the United Kingdom and it seeks comments on the deal by Oct. 11, it said.

Write to Kim Richters at kim.richters@wsj.com

(END) Dow Jones Newswires

September 25, 2019 02:39 ET (06:39 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Roche (QX) Charts.
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Roche (QX) Charts.